Physician profile
Daniel G Gorbett
NPI 1487816518
$56,800.94
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $9,036 · 2021: $15K · 2022: $277 · 2023: $376 · 2024: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $605.01 |
| Education | $107.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $55,662.32 | 2019-2024 | Tyvaso |
| Actelion Pharmaceuticals US, INC. | $485.09 | 2019-2024 | Opsumit, Uptravi |
| Genzyme Corporation | $112.29 | 2019-2024 | |
| Mylan Specialty L.P. | $71.70 | 2023 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $59.42 | 2020-2023 | |
| Glaxosmithkline, LLC. | $57.23 | 2019-2023 | Nucala, Trelegy Ellipta |
| Amgen INC. | $54.52 | 2023 | Tezspire, Tavneos |
| Sunovion Pharmaceuticals INC. | $42.14 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $38.51 | 2023 | Fasenra, Tezspire |
| Genentech USA, INC. | $38.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.97 | 2019 | |
| Sandoz INC. | $28.27 | 2023 | Treprostinil |
| Getinge USA Sales, LLC | $22.88 | 2022 | |
| Pharming Healthcare, INC. | $20.83 | 2023 | Ruconest |
| Merck Sharp & Dohme LLC | $18.09 | 2024 | Winrevair |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $15.18 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.24 | 2023 | Ultomiris |
| Insmed, INC. | $13.30 | 2019 | |
| Pulmonx Corporation | $12.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gorbett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.